Click to Download the Latest Investor Presentation. Subscribe to Investor updates: Full Name. Email *. Select your notifications *. Press Releases. SEC Filings.
Investors. INVESTOR PRESENTATION. Check here our latest Investor Presentation. View deck. UPCOMING EVENTS. Access our recent and upcoming events. Click here ...
Get the latest insights on CorMedix Inc. Common Stock (CRMD) with press releases and corporate news to help you in your trading and investing decisions.
People also ask
What does CRMD do?
What is the product of Cormedix?
Who manufactures Defencath?
Investor Relations. Overview; Financials. SEC Filings · Financial Reports · Fundamentals. News & Events. News Releases · Events · Presentations.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
CorMedix, Inc. Ticker CRMD. Exchange NYSE More ... Click the button below to request a report when hardcopies become available. ... 2021 Annual Report View Annual ...
Mar 12, 2024 · Please go ahead. Dan Ferry -- Investor Relations. Good morning and welcome to the CorMedix's full year 2023 earnings conference call. Leading ...
(Nasdaq: CRMD), a biopharmaceutical company ... A replay of each fireside chat will also be available in the "Events and Presentations" page on the investor ...
Aug 3, 2021 · New York, New York--(Newsfile Corp. - August 3, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit ...
Financials Investor Relations Estimates Industry Modeling Dividends Ownership Filings. Hide Summary. Basic. Market Cap. $321.09M. EV. $245.73M. Shares Out.